Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Multiple Myeloma 4Lymphoma, B-Cell 3Rectal Neoplasms 2Pancreatic Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Thyroid Cancer, Papillary 1Sarcoma, Synovial 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Low Anterior Resection Syndrome 1Liposarcoma, Myxoid 1Immunoglobulin Light-chain Amyloidosis 1Hematopoietic and Lymphatic System Neoplasm 1Epstein-Barr Virus Infections 1Duodenal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Adult Solid Neoplasm 1Adenocarcinoma, Follicular 1

Interventions

Iodine-131 5lenvatinib 3X-Rays 3Thyrotropin Alfa 3Magnetic Resonance Spectroscopy 3trametinib 2dabrafenib 2Sunitinib 2Specimen Handling 2Interviews as Topic 2vandetanib 1tremelimumab 1spartalizumab 1selpercatinib 1pembrolizumab 1pazopanib 1durvalumab 1cobimetinib 1cabozantinib 1Vemurafenib 1Thyrotropin 1Thalidomide 1Surgical Procedures, Operative 1Sorafenib 1Sodium Iodide 1Semaxinib 1Photons 1Photochemotherapy 1Phantoms, Imaging 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma, Follicular × Phantoms, Imaging × Clear all
NCT06959641 2026-05-22

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

Northwestern University

Phase 2 Recruiting
33 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡